Despite decades of compelling scientific evidence, Whole-Food Plant-Based Diets (WFPBDs) remain one
of the most underutilized, misunderstood, and undervalued medical interventions in modern healthcare.
This paper unpacks the disturbing paradox of why a clinically validated, cost-effective, and safe dietary
strategy capable of reversing chronic diseases—including coronary artery disease (CAD), type 2
diabetes mellitus (T2DM), hypertension, obesity, kidney dysfunction, and even early cancers—continues
to be marginalized. Drawing on nearly seven years of clinical experience at Bethsaida Hospital under
the visionary leadership of Prof. Dasaad Mulijono in Indonesia, we present transformative real-world
outcomes in over 6,000 patients, including zero mortality among high-risk elderly COVID-19 cases
treated with WFPBD and lifestyle medicine. The discussion explores why the medical community still
resists WFPBDs: cultural dogmas, food addiction, economic incentives, insufficient medical education,
and systemic bias in research funding. We argue that this resistance is no longer rooted in scientific
uncertainty, but in deeply entrenched institutional and psychological barriers. In a world where invasive
procedures are glorified and preventive solutions dismissed, embracing WFPBDs is not only a medical
necessity but a moral obligation. If we fail to act now, we are not just neglecting a dietary intervention—
we are denying patients the right to live.
